NMN — research review 2

...and this idea of NMN, nicotinamide mononucleotide, as a longevity supplement has gained a lot of traction. The basic idea is that NMN is a direct precursor to NAD+, a crucial molecule for cellular energy and repair.

Right. We know NMN is rapidly converted to NAD+ in tissues. Studies in mice, like one in Cell Metabolism in 2016, showed oral NMN was quickly utilized and mitigated age-associated physiological decline.

And it’s not just NAD+ production. NMN also activates SIRT1, a sirtuin protein linked to longevity. A 2011 study, again in Cell Metabolism, demonstrated NMN improved hepatic insulin sensitivity and restored gene expression, partly through SIRT1 activation.

It's also been shown to help with mitochondrial function. Cell Reports in 2020 found NMN's beneficial effect on aged oocytes involved restoring mitochondria and reducing reactive oxygen species. And a 2023 review in Advances in Nutrition linked NMN to mitigating oxidative stress, DNA damage, and neurodegeneration by increasing NAD+ concentrations.

So the animal data is pretty compelling, showing these mechanisms and benefits. But what about human evidence? This is where we need to be careful not to jump from mice to humans.

Exactly. While NMN is naturally found in foods like edamame and avocados, and calorie restriction also targets these NAD+/sirtuin pathways, direct human trials proving NMN extends human lifespan or healthspan are still largely unproven. We have initial safety data, but robust, large-scale clinical trials showing definitive anti-aging effects in humans are still ongoing or needed.

So for now, the longevity claims are mostly extrapolation from mechanistic animal studies. We don't have that definitive human evidence for widespread anti-aging effects yet.